Intelligent Finance and Economics APP learned that Ali Health (00241) has risen more than 7%, with an accumulated increase of over 20% after the performance announcement. As of press time, it has risen 6.2%, reporting HKD 3.77, with a turnover of HKD 248 million.

Dahua Jicheng published a research report stating that Ali Health's net income increased by 90.8% year-on-year to 1% revenue growth ending in March 2024, which significantly exceeded the expectations of the industry and the market. The management currently expects revenue to increase by 15% and net profit margin to reach 5% in the fiscal year 2025. The product structure is moving towards health products, and the marketing business continues to play a synergistic effect to improve operational efficiency.

Haitong International issued a research report stating that the company's revenue and profits in 2024 exceeded market expectations, with rapid growth in health products and medical instruments, steady increase in gross profit margin, and significant optimization of operating cost ratio. The bank believes that under the driving factors of industry such as increasing online and offline service penetration rates, external flow of prescriptions, and gradual improvement of online medical insurance policies, the company's business scale effect is expected to continue to expand.